Nippon India Nifty Pharma ETF
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Nifty Pharma ETF
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Exchange Traded Funds (ETFs)
Launch Date
: 21-Jun-2021
Fund Manager
: Jitendra Tolani
Net Assets (Rs. cr)
: 1760.51
Nippon India Nifty Pharma ETF - Nav Details
Nav Date
: 21-Sep-2026
NAV [Rs.]
: 27.7856
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: Nil
Nippon India Nifty Pharma ETF- NAV Chart
Nippon India Nifty Pharma ETF- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | 1.83 | 2.49 | 10.65 | 20.14 | 19.52 | 21.32 | 14.15 | 13.42 |
| Category Avg | 0.09 | -2.7 | -0.46 | 7.77 | 6.04 | 13.51 | 9.88 | 10.37 |
| Category Best | 4.06 | 5.32 | 17.69 | 39.58 | 83.3 | 46.91 | 29.21 | 115.95 |
| Category Worst | -3.64 | -7.16 | -15.39 | -13.69 | -24.93 | -2.52 | -2.69 | -21.72 |
Nippon India Nifty Pharma ETF- Latest Dividends
No Records Found
Nippon India Nifty Pharma ETF- Investment Details
Min. Investment(Rs.)
: 1000
Increm.Investment(Rs.)
: 0
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 20.75 | 1840784 | 365.35 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 11.88 | 220941 | 209.16 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 7.83 | 978190 | 137.84 |
| Equity | Laurus Labs | Pharmaceuticals & Biotechnology | 7.36 | 676401 | 129.53 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 7.34 | 254999 | 129.18 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 6.95 | 1059711 | 122.33 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 5.25 | 422174 | 92.38 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 4.69 | 481186 | 82.61 |
| Equity | Glenmark Pharma. | Pharmaceuticals & Biotechnology | 3.69 | 261749 | 64.91 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 3.08 | 101737 | 54.22 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 2.90 | 1240315 | 51.10 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 2.87 | 434941 | 50.50 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.71 | 241488 | 47.69 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 2.70 | 196801 | 47.61 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 2.27 | 138524 | 39.97 |
| Equity | Sai Life | Pharmaceuticals & Biotechnology | 1.99 | 239870 | 35.01 |
| Equity | Wockhardt | Pharmaceuticals & Biotechnology | 1.54 | 143561 | 27.04 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 1.50 | 73229 | 26.37 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 1.33 | 9055 | 23.40 |
| Equity | Piramal Pharma | Pharmaceuticals & Biotechnology | 1.32 | 1081282 | 23.18 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
7,67,506.41
Trustee/s:
Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Jitendra Tolani
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
